Eiger BioPharmaceuticals Inc

NASDAQ:EIGR   3:59:53 PM EDT
6.25
+0.33 (+5.57%)
Debt Financing / Related

Eiger Biopharmaceuticals Enters Into $75M Term Loan Agreement And $5M Stock Purchase Agreement With Innovatus Capital Partners To Refinance Existing Debt Facility And Further Strengthen Cash Pos

Published: 06/07/2022 20:32 GMT
Eiger BioPharmaceuticals Inc (EIGR) - Eiger Biopharmaceuticals Enters Into $75m Term Loan Agreement and $5m Stock Purchase Agreement With Innovatus Capital Partners to Refinance Existing Debt Facility and Further Strengthen Cash Position Ahead of Key Milestones.
Eiger Biopharmaceuticals - Company Expects Its Cash, Cash Equivalents, and Total Investments to Fund Planned Operations Through 2024.